Ratings by Rodman & Renshaw (Brandon Folkes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
1.29 (1.21) |
-6.2% | Details | |
| 1/28/2025 | Indivior | INDV | New Coverage | Buy (N/A) |
12.02 (40.54) |
237.27% | Details | |
| 1/28/2025 | Rein Therapeutics | RNTX | New Coverage | Buy (N/A) |
2.10 (0.86) |
-59.05% | Details | |
| 1/28/2025 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
3.15 (5.37) |
70.48% | Details | |
| 1/28/2025 | Talphera | TLPH | New Coverage | Buy (N/A) |
0.72 (1.33) |
84.72% | Details | |
| 11/14/2024 | Rockwell Medical Technologies | RMTI | New Coverage | Buy (N/A) |
2.63 (6.13) |
133.08% | Details | |
| 11/14/2024 | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (N/A) |
2.84 (6.59) |
132.04% | Details | |
| 11/14/2024 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
4.53 (6.27) |
38.41% | Details | |
| 11/14/2024 | Adial Pharmaceuticals Inc | ADIL | New Coverage | Buy (N/A) |
0.99 (2.80) |
182.83% | Details | |
| 11/14/2024 | Omeros Corp. | OMER | New Coverage | Buy (N/A) |
4.19 (9.69) |
131.26% | Details | |
| 8/26/2024 | CorMedix | CRMD | New Coverage | Buy (N/A) |
5.65 (8.42) |
49.03% | Details | |
| 6/13/2024 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
2.60 (19.07) |
633.46% | Details | |
| 6/13/2024 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
1.33 (8.44) |
534.59% | Details | |
| 6/13/2024 | Heron Therapeutics | HRTX | New Coverage | Buy (N/A) |
3.64 (0.47) |
-87.09% | Details | |
| 6/13/2024 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
4.01 (0.70) |
-82.54% | Details | |
| 6/13/2024 | MannKind | MNKD | New Coverage | Buy (N/A) |
4.65 (4.03) |
-13.33% | Details |
